Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Arm, Open-Label, Expanded Access Program for Lenalidomide With or Without Dexamethasone in Previously Treated Subjects With Multiple Myeloma

NCT00179647 is registered in ClinicalTrials.gov with Celgene Corporation as lead sponsor.

NCT NCT00179647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00179647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Arm, Open-Label, Expanded Access Program for Lenalidomide With or Without Dexamethasone in Previously Treated Subjects With Multiple Myeloma
Lead sponsor
Celgene Corporation
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
April 30, 2009
Enrollment
1,913 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma